The9 Ltd
NCTY
BIT Mining
BTCM
FRMO CORP
FRMO
Digihost Technology
DGHI
Abits
ABTS
US Stock MarketDetailed Quotes
ELTX Elicio Therapeutics
- 8.000
- -0.310-3.73%
Close Mar 26 16:00 ET
126.90MMarket Cap-1.84P/E (TTM)
8.310High8.000Low36.95KVolume8.255Open8.310Pre Close302.62KTurnover0.37%Turnover RatioLossP/E (Static)15.86MShares11.45052wk High-6.68P/B79.78MFloat Cap3.34252wk Low--Dividend TTM9.97MShs Float263.000Historical High--Div YieldTTM3.73%Amplitude2.960Historical Low8.190Avg Price1Lot Size
Elicio Therapeutics News
ELICIO THERAPEUTICS Earnings Preview: Recent $ELTX Insider Trading, Hedge Fund Activity, and More
Elicio Therapeutics Hires CFO From Cidara Therapeutics
Press Release: Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer
12 Health Care Stocks Moving In Friday's Pre-Market Session
JonesTrading Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Maintains Target Price $12
With 36% Ownership, Elicio Therapeutics, Inc. (NASDAQ:ELTX) Insiders Have a Lot at Stake
JonesTrading Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Raises Target Price to $12
Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and Elicio Therapeutics (ELTX)
Why Elicio Therapeutics Inc (ELTX) Is Skyrocketing So Far In 2025
Elicio Shares Slide After Follow-On Offering Prices at Discount
Express News | Elicio Therapeutics Enters Definitive Securities Purchase Agreement With Institutional Investors For Purchase Of 1,261,830 Shares At $7.925
Express News | Elicio Therapeutics Inc - Offering Closing Expected on or About January 30, 2025
Express News | Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Press Release: Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Elicio Therapeutics Advances With New Clinical Updates
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Elicio Therapeutics Gets FDA Support to Advance Cancer Immunotherapy, Plans Phase 3 Trial for ELI-002
Express News | Elicio Therapeutics: Phase 2 Randomized Study of Eli-002 Fully Enrolled, With Formal Interim Analysis of Disease-Free Survival Expected in H1 2025
Express News | Elicio Therapeutics Reaches Alignment With FDA on Eli-002 Registrational Strategy
Elicio Therapeutics Reaches Alignment With FDA on ELI-002 Registrational Strategy
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.